<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15-marinedrugs-17-00567">
 <label>15.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Levendosky</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Mizenina</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Martinelli</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Jean-Pierre</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Kizima</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Rodriguez</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kleinbeck</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Bonnaire</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Robbiani</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Zydowsky</surname>
    <given-names>T.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Griffithsin and carrageenan combination to target herpes simplex virus 2 and human papillomavirus</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2015</year>
  <volume>59</volume>
  <fpage>7290</fpage>
  <lpage>7298</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.01816-15</pub-id>
  <pub-id pub-id-type="pmid">26369967</pub-id>
 </element-citation>
</ref>
